Radboud University is a public research university located in Nijmegen, the Netherlands. The university bears the name of Saint Radboud, a 9th century Dutch bishop who was known for his intellect and support of the underprivileged.

During the past decade, Radboud University conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radboud University" #1 sponsor was "Radboud University Medical Center" with 13 trials, followed by "Jaeb Center for Health Research" with 3 trials sponsored, "PTC Therapeutics" with 2 trials sponsored, "AM-Pharma" with 1 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radboud University" #1 collaborator was "Radboud University Medical Center" with 4 trials as a collaborator, "Foundation Fighting Blindness" with 2 trials as a collaborator, "University Medical Center Groningen" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator and "ABX advanced biochemical compounds GmbH" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Radboud University" are "Colorectal Neoplasms" (2 trials), "Cystic Fibrosis" (2 trials), "Prostate Cancer" (2 trials), "Retinitis Pigmentosa" (2 trials) and "Abdominal Injuries" (1 trials). Many other conditions were trialed in "Radboud University" in a lesser frequency.

Most popular intervention types in "Radboud University" are "Drug" (11 trials), "Biological" (3 trials), "Device" (3 trials), "Diagnostic Test" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "177Lu-PSMA-617" (1 trials), "18F-PSMA-1007 PET/CT" (1 trials), "89Zr-Girentuximab" (1 trials) and "89Zr-avelumab PET" (1 trials). Other intervention names were less common.

The vast majority of trials in "Radboud University" are 26 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Radboud University". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Radboud University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Radboud University, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".